Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Weill Cornell Medicine Courses and Meetings
Avatar

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors and PD-1 and CTLA-4 Combination Immunotherapy

By Weill Cornell Medicine Courses and Meetings FEATURING Paul Chapman
By Weill Cornell Medicine Courses and Meetings FEATURING Paul Chapman
82 views
June 10, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Skin
29:16
Insights from 2023 IGCS Annual Meeting

IGCS 2023 Insights: "Vulvovaginal Melanoma - Current Approaches…

Feat. M. Leitao
24:53
OncoAlert

Recent Melanoma Updates

Feat. A. Betof Warner
04:04
GRACE

Clinical Trials in Melanoma

Feat. M. Postow
02:49
GRACE

Major Advances in Uveal Melanoma

Feat. M. Postow
04:28
GRACE

BRAF Mutated Melanoma

Feat. M. Postow
03:10
GRACE

Side Effects of Immunotherapy in Melanoma

Feat. M. Postow
08:00
GRACE

Immunotherapy in Treatment of Melanoma

Feat. M. Postow
05:50
GRACE

Melanoma and Current Treatment Options

Feat. M. Postow
11:42
Memorial Sloan Kettering Cancer Center

Who Should Be Getting Adjuvant Therapy in Melanoma?

Feat. A. Betof Warner
47:34
Massachusetts General Hospital Cancer Center

Confronting Inequity in Modern Therapy for Rare Melanomas

Feat. A. Shoushtari
10:11
Memorial Sloan Kettering Cancer Center

2022 Updates in the Treatment of Melanoma

Feat. M. Postow
06:32
Memorial Sloan Kettering Cancer Center

2021 ASCO Highlights on 1L Treatment for Advanced Melanoma: RELATIVI…

Feat. A. Betof Warner
15:05
Memorial Sloan Kettering Cancer Center

2020 Updates on Stage 4 Melanoma: Do BRAF+ MEK Combos Improve PFS? I…

Feat. A. Betof Warner
13:02
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Skin Toxicities are First and Frequent in Immunotherapy

Feat. M. Lacouture
14:10
Weill Cornell Medicine Courses and Meetings

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors a…

Feat. P. Chapman